EndoChoice has announced the pricing for its initial public offering of 6.35 million shares of common stock.
The common stock will be sold at $15 per share. EndoChoice stock is expected to begin trading on the New York Stock Exchange under the symbol "GI" today.
J.P. Morgan and BofA Merrill Lynch are acting as joint booking-running managers of the offering. William Blair and Stifel are co-managers of the offering.
The underwriters of the offering have a 30-day option to purchase up to an additional 952,000 shares.